The role of oxidative stress in diabetic complications

Current Opinion in Endocrinology and Diabetes

Volumn 3, Issue 4, 1996, Pages 277-284

  Baynes, John W ^a   Thorpe, Suzanne R ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842423094     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199608000-00001     Document Type: Article

References (64)

1. Wolff SP, Dean RT: Glucose autoxidation and protein modification: the potential role of autoxidative glycosylation in diabetes. Biochem J 1987, 245:243-250.
2. Wolff SP, Jiang ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med 1991, 10:339-352.
3. Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991, 88:1785-1792.
4. Grundy SM: Role of low density lipoprotein in atherogenesis and development of coronary heart disease. Clin Chem 1995, 41:139-146.
5. Giugliano D, Ceriello A, Paolisso G: Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress. Metabolism 1995, 44:363-368.
6. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996, 19:257-265. This is a comprehensive and current review of evidence on the role of hyperglycemia and oxygen radicals in diabetic vascular disease.
7. Soulis-Liparota T, Cooper ME, Dunlop M, Jerums G: The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia 1995, 38:387-394. This is an original paper with a thoughtful discussion of various mechanisms for development of diabetic nephropathy, concluding that oxidative stress is not involved. The studies were conducted in streptozotocin-diabetic rats receiving low-level insulin therapy for 8 months, an animal model that may be more relevant to chronic human diabetes than the acute, untreated diabetic rat model.
8. Stevens MJ, Feldman EL, Greene DA: The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet Med 1995, 12:566-579.
9. Cameron MA, Love A, Watt MJ, Cameron NE, Dines KC: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 1995, 38:1285-1294.
10. Baynes JW: Reactive oxygen in the aetiology and complications of diabetes. In Drugs, Diet and Disease: Mechanistic Approaches to Diabetes, vol 2. Edited by Ioannides C. London: Pergamon Press; 1995:203-240.
11. Paolisso G, D'Amore A, Volpe C, Balbi V, Saccomanno F, Galzerano D, Giugliano D, Varricchio M, D'Onofrio F: Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994, 43:1426-1429.
12. Paolisso G, Giugliano D: Oxidative stress and insulin action: is there a relationship? Diabetologia 1996, 39:357-363.
13. Cominacini L, Garbin U, LoCascio V: The need for a "free radical initiative." Diabetologia 1996, 39:364-366.
14. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K: Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979, 21:104-107.
15. Parthiban A, Vijayalingam S, Shanmugasundaram KR, Mohan R: Oxidative stress and the development of diabetic complications: antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biol Int 1995, 19:987-993.
16. Niskanen LK, Salonen JT, Nyyssönen, Uusitupa MIJ: Plasma lipid peroxidation and hyperglycaemia: a connection through hyperinsulinemia? Diabet Med 1995, 12:802-808.
17. Jentzsch AM, Bachmann H, Fürst, Bielsalski HK: Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996, 20:251-256. This paper describes a state-of-the-art procedure for conducting the TBARS assay.
18. McGill HC, McMahan CA, Malcom GT, Oalmann MC, Strong JP: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group: Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Aterioscler Thromb Vasc Biol 1995, 15:431-440. This paper describes correlations between atherosclerosis, glycohemoglobin, and obesity in nondiabetic persons, aged 15 to 34 years, suggesting that atherosclerosis in young adults is associated with a prediabetic or early diabetic state.
19. Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I: Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 1995, 18:646-653.
20. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH: Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 1993, 102:63-67.
21. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH: Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition. Diabetologia 1995, 38:1300-1306.
22. Rabini RA, Fumelli P, Galassi R, Dousset N, Taus M, Ferretti G, Mazzanti L, Curatola G, Solera ML, Valdiguié P: Increased susceptibility of lipid oxidation of low-density lipoprotein and erythrocyte membranes from diabetic patients. Metabolism 1994, 43:1470-1474.
23. Tsai EC, Hirsch IB, Brunzell JD, Chait A: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994, 43:1010-1014.
24. Reaven P: Dietary and pharmacologic regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1995, 62:1483S-1489S.
25. Parfitt VJ, Desomeaux K, Bolton CH, Hartog M: Effects of high monounsaturated and polyunsaturated fat diets on plasma lipoproteins and lipid peroxidation in type 2 diabetes mellitus. Diabet Med 1994, 11:85-91.
26. Reaven PD, Herold DA, Barnett J, Edelman S: Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and protein glycation in NIDDM. Diabetes Care 1995, 18:607-816.
27. Lyons TJ: Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes. Diabet Med 1991, 8:411-419.
28. Young IS, Trimble ER: Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorescence detection. Ann Clin Biochem 1991, 28:504-508.
29. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995, 44:1054-1058.
30. Hermes-Lima M, Willmore WG, Storey KB: Quantification of lipid peroxidation in tissue extracts based on Fe(III) xylenol orange complex formation. Free Radic Biol Med 1995, 19:271-280.
31. Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, Finardi G: Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 1995, 44:60-66.
32. Craig WY: Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology. J Clin Lab Anal 1995, 9:70-74. This is a critical review of the use and limitations of assays for αOx LDL for detection of vascular disease.
33. Philis-Tsimikas A, Parthasarathy S, Picard S, Palinski W, Witztum JL: Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arteriosder Thromb Vasc Biol 1995, 15:367-376.
34. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993, 42:221-232.
35. Stitt AW, Chakravarthy U, Archer DB, Gardiner TA: Increased endocytosis in retinal vascular endothelial cells grown in high glucose medium is modulated by inhibitors of nonenzymatic glycosylation. Diabetologia 1995, 38:1271-1275. This study notes that the increase in endocytic activity of endothelial cells in vivo can be mimicked in vitro by growing endothelial cells in high-glucose medium.
36. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 1994, 37:264-269.
37. 2 in high glucose medium. Diabetes 1995, 44:520-526.
38. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessi A, Wahdhäusl W: High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995, 44:1323-1327.
39. Kunisaki M, Bursell SE, Clermont, AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL: Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol 1995, 269:E239-E246. This is an excellent study showing that vitamin E therapy inhibits development of retinopathy in diabetic rats and illustrating that alterations in the protein kinase C pathway in diabetes and in retinal endothelial cells grown in hyperglycemic media are also reversible by vitamin E.
40. Cameron NE, Cotter MA: Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: evidence from experimental studies. Diabet Med 1993, 10:593-605.
41. Bravenboer B, Kapelle AC, Hamers FPT, van Buren T, Erkelens WD, Gispen WH: Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 1992, 35:813-817.
42. Sagara M, Satoh J, Wada R, Yagihashi S, Takahashi K, Fukuzawa M, Muto G, Muto Y, Toyota T: Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia 1996, 39:263-269.
43. Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995, 18:1150-1167.
44. Packer L, Witt EH, Tritschler HJ: Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995, 19:227-250.
45. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK: Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 1994, 37:449-459.
46. Cameron NE, Cotter MA, Maxfield EK: Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 1993, 36:299-304.
47. Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima E, Inukai S, Sakamoto N: Effect of a potent new aldose reductase inhibitor, (5-(3-thienyl)tetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats. Diabetes Res Clin Pract 1995, 27:107-117.
48. Stevens MJ: Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy. Diabet Med 1995, 12:292-295. This is a thoughtful review developing the relationship between biochemical abnormalities in polyol pathway and protein kinase C activity during hyperglycemia and subsequent alterations in nitric oxide metabolism and vascular tone.
49. Cameron NE, Cotter MA, Hohman TC: Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia 1996, 39:172-182. This is the latest of a series of papers on alternative approaches to the treatment of neuropathy in acutely and severely diabetic rats. The discussion reviews and integrates results of earlier studies from this laboratory.
50. Williamson JR, Chang K, Khalid MF, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993, 42:801-813.
51. Rösen P, Ballhausen T, Bloch W, Addicks K: Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 1995, 38:1157-1168. This study shows that administration of vitamin E protects the rat heart against functional and morphologic damage in diabetes, suggesting a role for vitamin E in the treatment of diabetic cardiomyopathy.
52. Keegan A, Walbank H, Cotter MA, Cameron NE: Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 1995, 38:1475-1478.
53. Strödter D, Lehmann E, Lehmann U, Tritschler H-J, Bretzel RG, Federlin K: The influence of thioctic acid on metabolism and function of the diabetic heart. Diabetes Res Clin Pract 1995, 29:19-26.
54. Bertuglia S, Malandrino S, Colantuoni A: Effects of the natural flavonoid delphinidin on diabetic microangiopathy. Arzneim Forsch / Drug Res 1995, 45:481-485.
55. Dai S, McNeill JH: Ascorbic acid supplementation prevents hyperlipidemia and improves myocardial performance in streptozotocin-diabetic rats. Diabetes Res Clin Pract 1995, 27:11-18.
56. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER: The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 1995, 18:833-840.
57. Christopher MM, Broussard JD, Peterson ME: Heinz body formation associated with ketoacidosis in diabetic rats. J Vet Intern Med 1995, 9:24-31.
58. Sinclair AJ, Taylor PB, Lunec J, Girling AJ, Barnett AH: Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabet Med 1994, 11:893-898.
59. Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA: Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996, 97:22-28.
60. Ceriello A, Giacomello R, Stel G, Motz E, Taboqa C, Tonutti L, Pirisi M, Falleti E, Bartoli E: Hyperglycemia-induced thrombin formation in diabetes: the possible role of oxidative stress. Diabetes 1995, 44:924-928. This is an interesting study showing a direct relationship between hyperglycemia, altered thrombogenic activity, and oxidative stress in control and diabetic patients.
61. Giugliano D, Marfella R, Verrazzo G, Acompora R, Donzella C, Quatraro A, Coppola L, D'Onofio F: Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants. Ann Intern Med 1995, 123:338-343.
62. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schütte K, Gries FA, The ALADIN Study Group: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. Diabetologia 1995, 38:1425-1433. This paper describes a short-term, well-controlled study illustrating the positive effects of thiol therapy on advanced neuropathy in diabetic patients.
63. Thornalley PJ: The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 1990, 269:1-11.
64. Yoshida K, Hirokawa J, Tagami S, Kawakami Y, Urata Y, Kondo T: Weakened cellular scavenging activity against oxidative stress in diabetes mellitus: regulation of glutathione synthesis and efflux. Diabetologia 1995, 38:201-210.